V. Dinnendahl

458 total citations
19 papers, 391 citations indexed

About

V. Dinnendahl is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, V. Dinnendahl has authored 19 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Cell Biology. Recurrent topics in V. Dinnendahl's work include Neuroscience and Neuropharmacology Research (7 papers), Ion channel regulation and function (3 papers) and Receptor Mechanisms and Signaling (3 papers). V. Dinnendahl is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Ion channel regulation and function (3 papers) and Receptor Mechanisms and Signaling (3 papers). V. Dinnendahl collaborates with scholars based in Germany. V. Dinnendahl's co-authors include S. W. Gumułka, K. Stock, P. S. Schönhöfer, D. Bartmus, D.A. Kalbhen and Robert K. Bohn and has published in prestigious journals such as Brain Research, Biochemical Pharmacology and Psychopharmacology.

In The Last Decade

V. Dinnendahl

19 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Dinnendahl Germany 11 181 156 79 67 47 19 391
Pauline Lerner United States 10 264 1.5× 179 1.1× 117 1.5× 17 0.3× 37 0.8× 19 524
Elizabeth B. Hollingsworth United States 13 403 2.2× 413 2.6× 71 0.9× 47 0.7× 40 0.9× 18 684
Carla Torri Italy 10 211 1.2× 166 1.1× 80 1.0× 35 0.5× 29 0.6× 15 437
F. Guilloux 8 371 2.0× 217 1.4× 64 0.8× 44 0.7× 33 0.7× 8 539
Masashi Takesada Japan 12 179 1.0× 162 1.0× 76 1.0× 30 0.4× 22 0.5× 15 584
Elizabeth Knyihár Hungary 13 364 2.0× 158 1.0× 254 3.2× 50 0.7× 63 1.3× 30 576
F. de Balbian Verster United States 12 257 1.4× 147 0.9× 122 1.5× 15 0.2× 39 0.8× 19 476
Elsa Regina Vinadé Brazil 10 163 0.9× 154 1.0× 41 0.5× 64 1.0× 36 0.8× 11 377
Peter‐A. Löschmann Germany 11 279 1.5× 256 1.6× 121 1.5× 119 1.8× 32 0.7× 12 653
K. Chen United States 9 157 0.9× 135 0.9× 56 0.7× 26 0.4× 41 0.9× 12 376

Countries citing papers authored by V. Dinnendahl

Since Specialization
Citations

This map shows the geographic impact of V. Dinnendahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Dinnendahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Dinnendahl more than expected).

Fields of papers citing papers by V. Dinnendahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Dinnendahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Dinnendahl. The network helps show where V. Dinnendahl may publish in the future.

Co-authorship network of co-authors of V. Dinnendahl

This figure shows the co-authorship network connecting the top 25 collaborators of V. Dinnendahl. A scholar is included among the top collaborators of V. Dinnendahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Dinnendahl. V. Dinnendahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gumułka, S. W., et al.. (1979). The effect of naloxone on cerebellar cGMP content. Naunyn-Schmiedeberg s Archives of Pharmacology. 306(2). 169–172. 29 indexed citations
2.
Gumułka, S. W., et al.. (1979). Baclofen and Cerebellar Cyclic GMP Levels in Mice. Pharmacology. 19(2). 75–81. 5 indexed citations
3.
Dinnendahl, V. & S. W. Gumułka. (1977). Stress-induced alterations of cyclic nucleotide levels in brain: Effects of centrally acting drugs. Psychopharmacology. 52(3). 243–249. 25 indexed citations
4.
Gumułka, S. W., et al.. (1977). On the mode of action of clonidine: Relationship between effects on behaviour and cyclic nucleotide content in mouse brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 298(1). 7–14. 5 indexed citations
5.
Schönhöfer, P. S., et al.. (1976). Lack of Relationship Between Cyclic Nucleotide Levels and Spermatozoal Function in Human Semen. Fertility and Sterility. 27(4). 403–406. 10 indexed citations
6.
Gumułka, S. W., et al.. (1976). Effects of stimulatory and depressant drugs on cyclic guanosine 3?,5?-monophosphate and adenosine 3?,5?-monophosphate levels in mouse brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 292(3). 259–265. 51 indexed citations
7.
Dinnendahl, V., et al.. (1976). Effects of benzydamine on the lipolytic system of fat cells. Biochemical Pharmacology. 25(3). 299–303. 2 indexed citations
8.
Dinnendahl, V., et al.. (1976). Catecholamine-induced lipolysis: Only via cyclic AMP?. Biochemical Pharmacology. 25(13). 1481–1484. 2 indexed citations
9.
Gumułka, S. W., et al.. (1976). Dopaminergic stimulants and cyclic nucleotides in mouse brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 295(1). 21–26. 6 indexed citations
10.
Gumułka, S. W., et al.. (1976). Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo. Naunyn-Schmiedeberg s Archives of Pharmacology. 293(1). 75–80. 26 indexed citations
11.
Dinnendahl, V. & K. Stock. (1975). Effects of arecoline and cholinesterase inhibitors on cyclic guanosine 3?,5?-monophosphate and adenosine 3?,5?-monophosphate in mouse brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 290(2-3). 297–306. 85 indexed citations
12.
Dinnendahl, V.. (1975). Effects of stress on mouse brain cyclic nucleotide levels in vivo. Brain Research. 100(3). 716–719. 34 indexed citations
13.
Dinnendahl, V., et al.. (1975). Mode of action of antirheumatic drugs on the cyclic 3?,5?-AMP regulated glycosaminoglycan secretion in fibroblasts. Naunyn-Schmiedeberg s Archives of Pharmacology. 289(1). 29–40. 11 indexed citations
14.
Dinnendahl, V.. (1974). A rapid and simple procedure for the determination of guanosine 3?,5?-monophosphate by use of the protein-binding method. Naunyn-Schmiedeberg s Archives of Pharmacology. 284(1). 55–61. 36 indexed citations
15.
Schönhöfer, P. S., et al.. (1973). Effects of sodium salicylate and acetylsalicylic acid on the lipolytic system of fat cells. Biochemical Pharmacology. 22(5). 629–637. 22 indexed citations
16.
Dinnendahl, V., et al.. (1973). Studies on the mechanism of the antilipolytic effect of paraoxon. Archives of Toxicology. 30(2). 175–182. 11 indexed citations
17.
Dinnendahl, V., et al.. (1973). Effects of antilipolytic drugs on cyclic 3?,5?-AMP dependent protein kinase. Naunyn-Schmiedeberg s Archives of Pharmacology. 278(3). 293–300. 5 indexed citations
18.
Dinnendahl, V., et al.. (1973). Effects of sodium salicylate and acetylsalicylic acid on cyclic 3′,5′-amp-dependent protein kinase. Biochemical Pharmacology. 22(18). 2223–2228. 23 indexed citations
19.
Bohn, Robert K., V. Dinnendahl, & D.A. Kalbhen. (1969). Automatisches Verfahren zur Bestimmung von sauren Mucopolysacchariden und seine Anwendung in der analytischen Biochemie. Fresenius Zeitschrift für Analytische Chemie. 247(5-6). 312–316. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026